Evidence-based Findings
Growth hormone (GH) is a key polypeptide hormone secreted by somatotroph cells in the anterior pituitary gland, essential for postnatal growth, metabolism, and systemic homeostasis [5]. The hormone exhibits significant molecular complexity, existing as a heterogeneous protein hormone consisting of several isoforms [3].
Molecular Structure and Isoforms
The diversity of GH stems from multiple sources [3]:
- Genomic level: The GH gene cluster on chromosome 17q contains 2 GH genes (GH1 or GH-N and GH2 or GH-V)
- mRNA splicing: Alternative splicing yields two main products - 22K-GH (the principal pituitary form) and 20K-GH
- Post-translational modifications: Include N(α)-acylated, deamidated and glycosylated forms, plus oligomeric structures
Regulation and Secretion
GH secretion is regulated by hypothalamic neuropeptides, including GH-releasing hormone and somatostatin [5]. The secretion patterns differ between isoforms [3]:
- Pituitary GH forms: Secreted in pulsatile fashion under hypothalamic control
- Placental GH-V: Secreted tonically with progressive rise during 2nd and 3rd trimester
Signaling Mechanisms
GH exerts effects through direct interaction with the growth hormone receptor and indirect pathways mediated by the GH-IGF-I axis [5]. Key signaling pathways include [5]:
- JAK-STAT pathway
- PI3K/AKT pathway
- MAPK pathway
These pathways promote cellular proliferation, differentiation, and metabolic balance [5].
Established Clinical Knowledge
Based on standard clinical practice, growth hormone serves multiple physiological functions:
Primary Functions
- Linear growth promotion in children and adolescents
- Metabolic regulation including protein synthesis, lipolysis, and glucose homeostasis
- Bone and cartilage development
- Muscle mass maintenance
- Organ development and function
Clinical Disorders
Dysregulation of GH results in diverse disorders [5], which can be categorized as:
#### GH Deficiency
- Congenital deficiencies: Including isolated GH deficiency and syndromic conditions like Turner syndrome, stemming from genetic mutations [5]
- Acquired deficiencies: Arising from trauma, tumors, infections, or autoimmune damage [5]
- Idiopathic deficiencies: Lacking identifiable causes [5]
#### GH Excess
GH overproduction causes gigantism in children and acromegaly in adults, often due to pituitary adenomas [5].
#### GH Resistance
Growth hormone resistance defines several genetic (primary) and acquired (secondary) pathologies that result in completely or partially interrupted activity of growth hormone [4]. The archetypal condition is Laron-type dwarfism caused by mutations in growth hormone receptors [4].
Therapeutic Approaches
Advances in therapy have transformed outcomes for GH disorders [5]:
#### For GH Deficiency
- Recombinant human growth hormone provides effective replacement therapy [5]
#### For GH Excess
- Somatostatin analogs
- Dopamine receptor agonists
- GH receptor antagonists [5]
- Surgical and radiotherapeutic interventions remain essential for pituitary adenomas [5]
#### For GH Resistance
Recombinant IGF-1 preparations are used in the treatment [4], particularly when standard GH therapy is ineffective due to receptor dysfunction.
Limitations
The available sources provide excellent coverage of GH molecular biology, signaling pathways, and general therapeutic approaches. However, they do not include specific dosing protocols, detailed treatment algorithms, or comprehensive adverse effect profiles that would be found in clinical practice guidelines.